pyrimidine dimers has been researched along with Chronic Illness in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moon, SD; Morgan, MB; Spencer, JM; Trapp, KM | 1 |
| Gabazza, EC; Hiyoyama, K; Inoue, A; Isaka, N; Kato, H; Kumeda, K; Nakano, T; Saito, Y; Shiku, H; Shimura, M; Suzuki, K; Takeya, H; Wada, H; Yamamuro, M | 1 |
2 trial(s) available for pyrimidine dimers and Chronic Illness
| Article | Year |
|---|---|
Topical formulation engendered alteration in p53 and cyclobutane pyrimidine dimer expression in chronic photodamaged patients.
Topics: Administration, Cutaneous; Adult; Aged; Chronic Disease; Dermatologic Agents; DNA Damage; DNA Repair; Follow-Up Studies; Humans; Middle Aged; Prospective Studies; Pyrimidine Dimers; Skin Aging; Treatment Outcome; Tumor Suppressor Protein p53; Ultraviolet Rays | 2013 |
Changes of plasma hemostatic markers during percutaneous transluminal coronary angioplasty in patients with chronic coronary artery disease.
Topics: alpha-2-Antiplasmin; Angioplasty, Balloon, Coronary; Biomarkers; Blood Coagulation Factors; Chronic Disease; Coronary Disease; Female; Humans; Lipoproteins; Male; Middle Aged; Protein C; Pyrimidine Dimers; Serine Proteinase Inhibitors; Thromboplastin | 1999 |